Mesenchymal stem cells (MSCs) are a type of adult stem cell that can be found in many tissues throughout the body, including the bone marrow, adipose tissue, and umbilical cord. MSCs have the ability to differentiate into a variety of cell types, including osteoblasts, chondrocytes, and adipocytes. In recent years, MSCs have been shown to possess immunoregulatory properties, making them a promising cell source for the treatment of a variety of immune-mediated diseases. The extraction of MSCs from the umbilical cord is a relatively simple and minimally invasive procedure. After the birth of a child, the umbilical cord is typically clamped and cut, and the remaining cord tissue is discarded. However, this cord tissue contains a large number of MSCs, which can be isolated and used for therapeutic purposes. To extract MSCs from the umbilical cord, a small incision is made in the cord, and a needle is inserted. The cord tissue is then aspirated into a syringe, and the cells are isolated using a centrifuge. The MSCs can then be cultured in vitro and used for a variety of therapeutic applications. The use of MSCs derived from the umbilical cord has a number of advantages over other cell sources. First, the umbilical cord is readily available and does not require any invasive procedures. Second, the MSCs isolated from the cord are young and have a high proliferative potential. Finally, the cord-derived MSCs are less likely to be rejected by the patient’s immune system, making them an ideal cell source for autologous cell therapy. MSCs isolated from the umbilical cord can be used for a variety of therapeutic applications, including the treatment of autoimmune diseases, graft-versus-host disease, and diabetes. In addition, cord-derived MSCs are being investigated as a potential cell source for regenerative medicine applications, such as the repair of damaged tissue and the regeneration of lost tissue.